Ligand Enters Into OmniAb® Platform License Agreement with Emergent BioSolutions
Go back to Ligand Enters Into OmniAb® Platform License Agreement with Emergent BioSolutions| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.79 +0.02 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.77 | 52 Week High | $44.38 | |||
| Open | $6.79 | 52 Week Low | $24.47 | |||
| Day High | $6.85 | P/E | 339.50 | |||
| Day Low | $6.67 | EPS | $0.02 | |||
| Volume | 631,362 | |||||
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 301.52 +2.48 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $299.04 | 52 Week High | $139.79 | |||
| Open | $303.17 | 52 Week Low | $82.07 | |||
| Day High | $305.35 | P/E | 701.21 | |||
| Day Low | $293.90 | EPS | $0.43 | |||
| Volume | 305,798 | |||||
